Clinical Trials Logo

Clinical Trial Summary

The effect of microbial exposure on healthy human subjects will be investigated. Changes in cytokine and IgE and vaccine response will be measured. The hypothesis is that microbial exposure increases the measured responses.


Clinical Trial Description

The effect of microbial exposure on healthy human subjects will be investigated. The volunteers will either receive material containing a microbial inoculum, or they will receive nothing. Changes in cytokine and IgE and vaccine response will be measured. Subjective well-being will be recorded. Changes in microbial community will be followed. The hypothesis is that microbial exposure increases the measured responses. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03351543
Study type Interventional
Source Helsinki University
Contact
Status Completed
Phase Phase 1
Start date March 2016
Completion date July 2017

See also
  Status Clinical Trial Phase
Completed NCT00224874 - Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) Phase 2
Completed NCT01002742 - Acute Graft-versus-Host Disease Treatment (BMT CTN 0802) Phase 3